Seasoned executive brings extensive leadership experience spanning corporate development, business development and pipeline ...

Dr. Maki brings nearly 20 years of biotechnology and pharma business development expertise as Company rapidly advances its powerful LNP platform to deliver mRNA-based therapies MENLO PARK, Calif. & ...

Chinese drugmaker Jiangsu Hengrui Pharmaceuticals has agreed to develop up to 12 of its drugs with British pharmaceutical giant GSK. Hengrui Pharma granted GSK an exclusive worldwide licence to its ...

MM+M held its third in-person Media Summit at Convene in New York City on Wednesday. The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) ...

The pandemic led to massive increases in research and development among pharmaceutical companies as they raced to discover vaccines and treatments for Covid-19. But those days are over, and many ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

The pharmaceutical business model relies on clinically testing many compounds to approve a single blockbuster that recoups all investments. The challenge in drug development is that clinical efficacy ...

Deloitte attributed rising R&D costs to increases in trial times, complex research areas, economic factors, tech advancements and high attrition rates. (iStock / Getty Images Plus) The average cost ...

Royalty Pharma plc (NASDAQ:RPRX) said it has entered into a research and development co-funding agreement with Johnson & Johnson (NYSE:JNJ) valued at $500 million to support the development of ...

During a June 2025 trade mission to the United Kingdom and France, Virginia Economic Development Partnership leaders and then-Gov. Glenn Youngkin met with AstraZeneca officials. Thirty-three days ...

Orchid Pharma surged 8.51% to Rs 1,005.50 after the company has entered into licensing and supply agreement with Pharmasyntez JSC (Pharmasyntez) to commercialize anitbotic, Exblifep in Russia.